The increasing number of generic budesonide inhaler releases is a significant driving force for the growth of the budesonide inhaler market. The rising prevalence of chronic obstructive pulmonary disease and asthma in the United States is predicted to drive the budesonide inhaler industry. The rising prevalence of chronic obstructive pulmonary disease and asthma in the United States is predicted to drive the budesonide inhaler industry. Furthermore, product recall is a key impediment to the growth of the worldwide budesonide inhaler market throughout the predicted period. Major market companies are focusing on creating generic versions of budesonide inhalers at reasonable pricing. Asthmatic patients can use dry powder, aerosols, suspensions, or sprays. A key element driving growth in the budesonide inhaler market is the increasing number of regulatory approvals for generic versions of the drug.
According to Coherent Market Insights, Global Budesonide Inhaler Market size was valued at US$ 6,899.6 Million in 2022 and is expected to witness a CAGR of 6.0% over the forecast period (2022 – 2030).
Leading Companies in the Budesonide Inhaler Industry:
1. Pfizer Inc.
Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sell biopharmaceutical products worldwide. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc.
2. Cipla Limited
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company was incorporated in 1935 and is headquartered in Mumbai, India.
3. Lupin Limited
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. t operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. In August 2020, Lupin Limited (Lupin), a pharmaceutical company, announced that it received approval from the U.S. Food and Drug Administration (FDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation, a generic version of ProAir HFA (Albuterol Sulfate Inhalation Aerosol).
4. Cosmo Pharmaceuticals
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. The company has a license agreement with RedHill Biopharma Ltd.; and Acacia Pharma Group plc. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland. On 4 October 2021 Cosmo Pharmaceuticals N.V. launched a public exchange offer under Swiss takeover rules to fully acquire and delist Cassiopea S.p.A
5. Takeda Pharmaceutical Company Ltd.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Taked, Zedira and Dr. Falk Pharma GmbH in October, 2022 announced a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the treatment of celiac disease. Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors on January 10, 2022.
6. Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.in June 2017, it is confirmed the announcement by Abbott Laboratories of their acquisition of St. Jude Medical. With this acquisition, Abbott has established itself as a leader in the medical device arena.
7. Novartis International AG (Sandoz)
The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. In January 2020, Novartis AG announced that it had completed acquisition of The Medicines Company, a pharmaceutical company.
8. AstraZeneca Plc
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development,zmanufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153.
9. Synmosa Biopharma Corporation
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. The company was incorporated in 1980 and is based in Taipei, Taiwan. Synmosa Group Acquire Health Chemical Pharmaceutical Corp. on April 2014.
*Defintion-Budesonide is an asthma medicine that is used to prevent symptoms. It is a corticosteroid, sometimes known as a steroid (cortisone-like medicine).
